RAP - The Next Phase, page-1931

Nothing is certain but it was definitely de-risk, IMO, when they released those excellent preliminary adult clinical trial results accuracy at 95-100% which was well above my expectation, especially given the initial pediatric results was only 80% which had to be improved to 95% in a month. I thought 45-50c would have held then, maybe I could be still right and it's getting back to those level after the Brexit and QU dumping of 40M+ shares halted it for a while?